Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Life Sciences Sector Offers Investors Growth, But at a Price.(Brief Article)
- Impressive growth rates tempered by high valuations. INVESTORS SEEKING higher growth opportunities in the chemical-based arena may want to take a closer look at the emerging life sciences industry, where companies are applying chemistry to dev Impressive growth rates...
- Research articles 2000-11-27
- BASF Unveils Massive Program For Expanding in North America.
- BASF CORPORATION plans to invest $4 billion in new plants and expansions in the Nafta region during the next five years to strengthen its position in one of the world's key growth markets. Nearly $2 billion will be targeted toward chemicals (see st BASF...
- Research articles 1998-09-28
- Timeline: The ABCs of the Changing Chemical Landscape.(Brief Article)
- This century has brought dramatic transformation to the global chemical industry: mergers and acquisitions, e-commerce, shifts to the life sciences and specialty chemicals, greater oil and petrochemical integration. Following is a snapshot review, This century has brought dramatic transformation to the global ...
- Research articles 1999-12-20
- Cambrex Reports Another Record Quarter.(first quarter 2000)(Brief Article)(Statistical Data Included)
- CAMBREX CORPORATION achieved record sales and earnings during the first quarter. The company's earnings rose to $12.3 million, compared to $10.2 million in the first quarter of 1999, a 20.9 percent increase. Gross sales climbed to $129 million, up CAMBREX CORPORATION achieved record...
- Research articles 2000-05-01
- European specialty players revamp and replace their strategy. (Focus 2003: Specialty Chemicals/ChemSpec Europe Preview).
- Threatened with commoditization, companies take drastic measures, not only cutting costs and divesting operations, but also seeking an entirely different, closer relationship with their customers. Under pressure from sluggish demand, difficult Threatened with commoditization, companies take drastic measures, ...
- Research articles 2003-04-28
- Bayer Unleashes Massive Effort In Biopharma
- Company may seek partners to strengthen its research in life sciences by 2002. BAYER IS PLANNING to spend around three quarters of its research budget on pharmaceuticals, diagnostics, crop protection and animal health by 2002 with the aim of maki Company may...
- Research articles 1998-06-22
- AHP and Monsanto Merge to Form Colossal Life Science Firm.
- New company will dominate ag chemicals and biotech. AMERICAN HOME Products Corporation and Monsanto Company arc planning to merge in a $33 billion tax-free stock swap, creating the world's largest life sciences company with 75,000 employees and $2 New company will dominate ag...
- Research articles 1998-06-08
- Bio-Rad Laboratories, Inc. Q3 2008 Earnings Call Transcript
- Earnings Call ExcerptBio-Rad Laboratories, Inc. BIO Q3 2008 Earnings Call November 6, 2008 5:00 pm ET Executives Ronald Hutton – Treasurer Christine Tsingos – Chief Financial Officer, Vice President John Goetz – Vice President, Group Manager - Clinical Diagnostics Group Norman Schwartz – President, Chief Executive Officer Brad...
- Earnings calls 2008-11-06
- Active Pharmaceuticals ingredient watch. (Markets: Life Sciences).(Abbott Laboratories reports 2001 sales of $16.3 bn)(Brief Article)(Statistical Data Included)
- ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over year, which includes US pharmaceuticals sales of $3.76 billion and international pharmaceuticals sales of $2.52 billion. ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over...
- Research articles 2002-01-21
- Ivax wins round in Pacitaxel patent battle, is likely to remain. (Markets: Life Sciences).(paving the way for continued sales of a generic version of Bristol-Myers Squibb Co.)(Brief Article)
- IN A GENERICS battle in the $1 billion US branded paclitaxel market, Ivax Corp. has won a key patent lawsuit in a federal district court in California, paving the way for continued sales of the company's generic version of Bristol-Myers Squibb Comp IN A...
- Research articles 2002-01-21
- Total Contract Management With SAP for Life Sciences
- The dynamics of today's economy require pharmaceutical companies to rigorously manage costs and government compliance as they attempt to increase market share with innovative sales strategies. To ensure profitable growth, companies are responding faster to changing market demands, requiring well-defined goals. This is especially true in the areas of sales...
- White papers 2004-08-26
- Bio-Rad Laboratories, Inc. Q2 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator instructions Your first question comes from the line of Larry Solow of CJS Securities. Please proceed. Larry Solow – CJS Securities Hi, good afternoon. Christine, could you talk a little bit about trends you are seeing in the life sciences market and stimulus funds, I know...
- Earnings calls 2009-08-04
- Achieving High Performance Through Product Launch Management
- Launching products into the pharmaceutical market has never been more crucial and challenging for life science companies seeking to achieve high performance. A product launch nowadays has to be 'Faster' - enhanced uptake of top line sales, 'Better' - accelerated growth and higher peak sales, and 'Cheaper' - executed with...
- White papers 2009-04-07
- Pfizer enjoys strong second quarter results. (Markets: life sciences
- BOLSTERED BY THE completion of its acquisition of Pharmacia Corp., Pfizer Inc. posted underlying earnings of $2.4 billion in the second quarter, or 30 cents per share on an adjusted basis, on a 37 percent surge in revenues to $10 billion. ...
- Research articles 2003-08-04
- Novartis AG. (Markets: Life Sciences).(Brief Article)
- NOVARTIS AG posted first quarter profit up 20 percent to SFr 1.8 billion ($1 billion) on sales ... NOVARTIS AG posted first quarter profit up 20 percent to SFr 1.8 billion ($1 billion) on sales up 14 percent to SFr 5 billion. Sales of ...
- Research articles 2002-04-29
- Biotech's Biogen, Serono lead off first quarter. (Markets: Life Sciences).(Brief Article)
- BIOGEN AND SERONO led a round of first quarter earnings last week in the biotechnology sector. Biogen Inc. lowered 2002 earnings guidance on the unveiling of an immuno-therapy drug pact and competitive pressure in the $1 billion US market for its m BIOGEN AND...
- Research articles 2002-04-29
- Amgen posts solid first quarter from Neulasta and Aranesp sales. (Markets: Life Sciences).
- AMGEN INC. posted solid first quarter results on strong sales of second-generation drugs Neulasta pegfilgrastim and Aranesp darbepoetin alfa. Amgen projects earnings per share for 2003 of $1.80 to $1.90 versus its previous estimate of $1.70 to AMGEN INC. posted solid first quarter...
- Research articles 2003-04-28
- C3i Appoints Carl Vanhaesendonck to Sales Director of Europe; Firm to Support Global Life Sciences Customers from Its Operations Centre in Sofia, Bulgaria
- BRUSSELS, Belgium -- C3i, the market leader in customer management support solutions for the life sciences industry, today announced the appointment of Carl Vanhaesendonck to director of EMEA sales, effective immediately. Formerly an executive sales manager with Cegedim Group, Mr. Vanhaesendonck will focus on expanding C3i's services to European companies...
- Research articles 2005-11-16
- DSM leaps ahead in life sciences with Roche purchase. (News: Europe).(Brief Article)
- DSM HAS moved to transform itself into a predominantly life sciences products company, agreeing last week to take over Roche's vitamins and fine chemicals (V&FC) division. Until the completion of the sale of its petrochemicals business to DSM...
- Research articles 2002-09-09
- Mylan wins FDA approval for generic Accutane. (Markets: Life Sciences).(Brief Article)
- MYLAN LABORATORIES Inc. has received Food and Drug Administration FDA approval for its generic version of Roche's acne drug Accutane/Roaccutan isotretinoin. Mylan's branded subsidiary Bertek Pharmaceuticals Inc. will market isotretinoin u MYLAN LABORATORIES Inc. has received Food and...
- Research articles 2002-11-18
- << Previous
- page 1 of 2
- Next >>
